Učitavanje...
Cost Effectiveness of Trastuzumab for Management of Breast Cancer in India
PURPOSE: We undertook this study to evaluate the incremental cost per quality-adjusted life-year (QALY) gained with use of adjuvant trastuzumab as compared with chemotherapy alone among patients with nonmetastatic breast cancer in India. METHODS: We used a Markov model to estimate the incremental co...
Spremljeno u:
| Izdano u: | JCO Glob Oncol |
|---|---|
| Glavni autori: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Society of Clinical Oncology
2020
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7051799/ https://ncbi.nlm.nih.gov/pubmed/32045547 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JGO.19.00293 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|